 | Up a level |
Number of items: 1.
Georgiev, P. G., Belada, D., Dakhil, S., Inhorn, L. F., Andorsky, D., Liberati, A. M., Beck, J. T., Quick, D., Patti, C., Sivcheva, L., Zaucha, J. M., Pettengell, R., Devries, T., Dean, J. P., Pavlyuk, M., Failloux, N. and Huebel, K. (2016). Phase 3 trial of pixantrone plus rituximab versus gemcitabine plus rituximab in treating relapsed/refractory transplant-ineligible aggressive non-Hodgkin's lymphoma. Ann. Oncol., 27. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041